| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
Designated Extension States: |
|
AL LT LV MK |
| (30) |
Priority: |
29.07.2002 GB 0217503
30.09.2002 US 415124 P
|
| (71) |
Applicants: |
|
- Novartis AG
4056 Basel (CH)
BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT
- Novartis Pharma GmbH
1230 Wien (AT)
AT
|
|
| (72) |
Inventors: |
|
- LI, Sau Wei,Novartis Horsham Research Centre
Horsham,West Sussex RH12 5AB (GB)
- POLL, Christopher T.,Novartis Horsham Res. Ctr.
Horsham,West Sussex RH12 5AB (GB)
- WESTWICK, John,Novartis Horsham Research Centre
Horsham,West Sussex RH12 5AB (GB)
- GOSLING, Martin,Novartis Horsham Research Centre
Horsham,West Sussex RH12 5AB (GB)
|
| (74) |
Representative: Hillebrand, Dirk, Dr. |
|
Novartis AGCorparate Intellectual Property
4002 Basel
4002 Basel (CH) |
|
